Medications for Secondary Hyperparathyroidism

4 results
  • parsabiv - etelcalcetide injection, solution

    (Etelcalcetide)
    Amgen, Inc
    PARSABIV treats secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis. Not recommended for parathyroid carcinoma, primary hyperparathyroidism, or chronic kidney disease patients not on hemodialysis.
  • rayaldee - calcifediol capsule, extended release

    (Calcifediol)
    Opko Pharmaceuticals Llc
    RAYALDEE, a vitamin D analog, treats secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D levels below 30 ng/mL. Not indicated for stage 5 chronic kidney disease or end-stage renal disease requiring dialysis.
  • zemplar - paricalcitol capsule, liquid filled

    (Paricalcitol)
    Abbvie Inc.
    Zemplar is a vitamin D analog indicated for the prevention and treatment of secondary hyperparathyroidism in adults and pediatric patients (10+) with chronic kidney disease (CKD) Stages 3 and 4, and CKD Stage 5 patients on hemodialysis or peritoneal dialysis.